Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950123-18-008882
Filing Date
2018-08-14
Accepted
2018-08-14 16:09:41
Documents
45
Period of Report
2018-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K UroGen-urgn-cover_6.htm 6-K 28061
2 EX-99.1 UroGen-urgn-ex991_20180630.htm EX-99.1 734095
3 EX-99.2 UroGen-urgn-ex992_7.htm EX-99.2 205528
4 EX-99.3 UroGen-urgn-ex993_278.htm EX-99.3 260503
5 GRAPHIC gd30tlsjdvjo000001.jpg GRAPHIC 2907
  Complete submission text file 0000950123-18-008882.txt   3155783

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT urgn-20180630.xml EX-101.INS 460021
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20180630.xsd EX-101.SCH 25957
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT urgn-20180630_cal.xml EX-101.CAL 26852
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT urgn-20180630_def.xml EX-101.DEF 68978
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT urgn-20180630_lab.xml EX-101.LAB 193934
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT urgn-20180630_pre.xml EX-101.PRE 147011
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38079 | Film No.: 181017537
SIC: 2834 Pharmaceutical Preparations